SWOG clinical trial number
SWOG-153

5-(3, 3-bis(2-chloroethyl)-1-triazene)-Imidazole-4- Carboxamide (TIC-mustard, NSC-82196) for Patients with Advanced Malignant Disease

Closed
Phase
I
Abbreviated Title
5-(3, 3-bis(2-chloroethyl)-1-triazene)-Imidazole-4- Carboxamide (TIC-mustard, NSC-82196) for Patients with Advanced Malignant Disease
Activated
08/03/1970
Closed
10/21/1971